Meet our experts

Management

With Arex, you have a full suite of expertise at your fingertips. 

Linda Thunell

Founding partner
CEO

MSc Tox

Staffan Thunell

Founding partner

BSc Economics and BA

Lovisa Rosenquist

Founding partner
Director Post-Marketing Projects

BSc Mol Cell Biol

Erik Hedner

Founding Partner
Director Drug Development

MBA, PhD in Medicinal Chemistry

Nelly Fransén

Partner
Head of Drug Development
Based in Lund, Sweden

 PhD in Pharmaceutical Sciences

Susanne Schuurman

Partner
Head of Market Access

MSc Health Economics

Emelie Terenius

Partner
CFO

BSc Business and Economics

Ann Kjellgren

Communications Director

MSc Media & Communication

Katarina Alheim

Partner
Chief Quality Officer

PhD in Neurochemistry and Neurotoxicology

Linda Thunell

Founding partner
CEO

MSc Tox

During her 25 years in the pharma­ceutical industry Linda has held various executive positions, and between 2002 and 2019 she was the founder and CEO of Sofus Regulatory Affairs AB. She has also worked as Head of Regulatory Affairs in pharma companies and as assessor at the Swedish Medical Products Agency.

Staffan Thunell

Founding partner

BSc Economics and BA

Staffan has a long background in entrepreneurship within the life science industry. He has 20+ years experience from posit­ions as Founder, Chair­man, CEO and CFO within medical affairs consulting and small pharma. Previously Staffan worked in executive positions in big pharma and specialty pharma companies.

Lovisa Rosenquist

Founding partner
Director Post-Marketing Projects

BSc Mol Cell Biol

Lovisa is a senior regulatory project manager with extensive experience from leading positions at consult­ancies, managing Nordic as well as global projects. She specialises in assisting companies with market entry and product launch activities. Lovisa started her career at the European Medicines Agency (EMA).

Erik Hedner

Founding partner
Director Drug Development

MBA, PhD in Medicinal Chemistry

Erik specialises in areas related to drug development and regulatory CMC. After a PhD in Medicinal Chemistry he worked as a CMC assessor at the Swedish Medicinal Products Agency. He has since held various expert positions within pharma consulting, primarily with a focus on CMC in phase I-III projects.

Nelly Fransén

Partner
Head of Drug Development
Based in Lund, Sweden

PhD in Pharmaceutical Sciences

Nelly specialises in formulation development, regulatory CMC and quality assurance. Her expertise includes formulation technologies and drug absorption from development to tech transfer, scale up and production support. Nelly supports our clients with expert advice on CMC documentation, regulatory strategies, product and process improvements, QA assignments within both GDP and GMP such as QMS set-up, acting responsible person, qualified person or performing audits. She is a Pharmacist with a Doctorate in Pharmaceutical Sciences from Uppsala University, and has previously worked as Director R&D and Responsible Person GDP in a smaller pharmaceutical company.

Susanne Schuurman

Partner
Head of Market Access

MSc Health Economics

Susanne specializes in strategic market access and HTA. Her expertise includes strategic landscape assessments, development of reimbursement dossiers and stakeholder interactions. She has experience as project manager for a variety of strategic market access projects, from phase II to post-marketing. She has previously worked at a global consultancy firm.

Emelie Terenius

Partner
CFO

BSc Business and Economics

Emelie joined Arex after working at KPMG, where her most recent position was Project Coordinator International Tax. Emelie has also worked as a tax officer at the Swedish Tax Agency and as Head of Tax and Legal at a non-profit organisation.

Ann Kjellgren

Communications Director

MSc Media & Communication

Ann is a professional in branding and communication with strong experience of leading teams and developing effective strategies. Most recently she worked as Client Service Director at the global agency Up There, Everywhere. She is a graduate of Uppsala University.

Katarina Alheim

Partner
Chief Quality Officer

PhD in Neurochemistry and Neurotoxicology

Katarina specialises in quality assurance and pharmacovigilance. She has specific experience in quality management systems, both for GDP and for pharmacovigilance work. Katarina has held the position of Responsible Person for many years and has experience from inspections by most of the Nordic Competent Authorities for medicine. She holds a PhD in Neurochemistry and Neurotoxicology from Stockholm University.